Acute dosing of latrepirdine (Dimebon™), a possible Alzheimer therapeutic, elevates extracellular amyloid-β levels in vitro and in vivo

BACKGROUND: Recent reports suggest that latrepirdine (Dimebon™, dimebolin), a retired Russian antihistamine, improves cognitive function in aged rodents and in patients with mild to moderate Alzheimer's disease (AD). However, the mechanism(s) underlying this benefit remain elusive. AD is charac...

Descripción completa

Detalles Bibliográficos
Autores principales: Steele, John W, Kim, Soong H, Cirrito, John R, Verges, Deborah K, Restivo, Jessica L, Westaway, David, Fraser, Paul, Hyslop, Peter St George, Sano, Mary, Bezprozvanny, Ilya, Ehrlich, Michelle E, Holtzman, David M, Gandy, Sam
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806870/
https://www.ncbi.nlm.nih.gov/pubmed/20017949
http://dx.doi.org/10.1186/1750-1326-4-51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806870/
https://www.ncbi.nlm.nih.gov/pubmed/20017949
http://dx.doi.org/10.1186/1750-1326-4-51

Ejemplares similares